Cargando…

Two cases of variant late infantile ceroid lipofuscinosis in Jordan

BACKGROUND: Late infantile ceroid lipofuscinosis is a rare neurodegenerative disorder that appears between the ages of 2 and 4 years and is difficult to diagnose. In this report we present two sisters with this condition, and the clinical course consisted of delayed developmental skills initially an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nafi, Omar, Ramadan, Bashar, Riess, Olaf, Buchert, Rebecca, Froukh, Tawfiq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354087/ https://www.ncbi.nlm.nih.gov/pubmed/30705896 http://dx.doi.org/10.12998/wjcc.v7.i2.203

Ejemplares similares

Late infantile neuronal ceroid lipofuscinosis: A case report with review of literature
por: Verma, Rajesh, et al.
Publicado: (2013)

Exome Sequencing Is an Efficient Tool for Variant Late-Infantile Neuronal Ceroid Lipofuscinosis Molecular Diagnosis
por: Patiño, Liliana Catherine, et al.
Publicado: (2014)

Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfa
por: Schaefers, J., et al.
Publicado: (2021)

A Murine Model of Variant Late Infantile Ceroid Lipofuscinosis Recapitulates Behavioral and Pathological Phenotypes of Human Disease
por: Morgan, Jeremy P., et al.
Publicado: (2013)

A novel cathepsin D mutation in 2 siblings with late infantile neuronal ceroid lipofuscinosis
por: Thottath, Jineesh, et al.
Publicado: (2019)

MRI findings in neuronal ceroid lipofuscinosis
por: Crain, Anna M., et al.
Publicado: (2020)

Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis
por: Ren, Xiao-Tun, et al.
Publicado: (2019)

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis
por: Huhtala, Tuulia, et al.
Publicado: (2012)

Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model
por: Koster, Kevin P, et al.
Publicado: (2019)

Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis
por: Nemtsova, Yuliya, et al.
Publicado: (2018)

Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis
por: Lange, Jenny, et al.
Publicado: (2018)

MRI findings of neuronal ceroid lipofuscinosis in a cat
por: White, Crystal, et al.
Publicado: (2018)

OPTICAL COHERENCE TOMOGRAPHY IN JUVENILE NEURONAL CEROID LIPOFUSCINOSIS
por: Hansen, Michael S., et al.
Publicado: (2016)

Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease – a new type of neuronal ceroid lipofuscinosis (CLN15)?
por: Beck-Wödl, Stefanie, et al.
Publicado: (2018)

A first CLN6 variant case of late infantile neuronal ceroid lipofuscinosis caused by a homozygous mutation in a boy from China: a case report
por: Sun, Guilian, et al.
Publicado: (2018)

Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset
por: Groh, Janos, et al.
Publicado: (2021)

Crystal Structure and Autoactivation Pathway of the Precursor Form of Human Tripeptidyl-peptidase 1, the Enzyme Deficient in Late Infantile Ceroid Lipofuscinosis
por: Guhaniyogi, Jayita, et al.
Publicado: (2009)

Systemic Administration of Tripeptidyl Peptidase I in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis: Effect of Glycan Modification
por: Meng, Yu, et al.
Publicado: (2012)

A Critical Tryptophan and Ca(2+) in Activation and Catalysis of TPPI, the Enzyme Deficient in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis
por: Kuizon, Salomon, et al.
Publicado: (2010)

Chronic Enzyme Replacement to the Brain of a Late Infantile Neuronal Ceroid Lipofuscinosis Mouse Has Differential Effects on Phenotypes of Disease
por: Wiseman, Jennifer A., et al.
Publicado: (2017)

Adult-Onset Neuronal Ceroid Lipofuscinosis in a Shikoku Inu
por: Tamura, Shinji, et al.
Publicado: (2021)

Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)
por: Katz, Martin L, et al.
Publicado: (2014)

Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
por: Sindelar, Miriam, et al.
Publicado: (2018)

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders
por: Kim, Kyeongsoon, et al.
Publicado: (2017)

First Record Mutations in the Genes ASPA and ARSA Causing Leukodystrophy in Jordan
por: Froukh, Tawfiq
Publicado: (2019)

ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis
por: Schmutz, Isabelle, et al.
Publicado: (2019)

Novel CLN1 mutation with atypical juvenile neuronal ceroid lipofuscinosis
por: Khan, Arif, et al.
Publicado: (2013)

Atypical juvenile neuronal ceroid lipofuscinosis: A report of three cases
por: Setty, Gururaj, et al.
Publicado: (2013)

Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy
por: Santorelli, Filippo Maria, et al.
Publicado: (2013)

Editorial: Neuronal ceroid lipofuscinosis: A multidisciplinary update
por: Simonati, Alessandro, et al.
Publicado: (2022)

Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder
por: Privitera, Flavia, et al.
Publicado: (2023)

Towards Splicing Therapy for Lysosomal Storage Disorders: Methylxanthines and Luteolin Ameliorate Splicing Defects in Aspartylglucosaminuria and Classic Late Infantile Neuronal Ceroid Lipofuscinosis
por: Banning, Antje, et al.
Publicado: (2021)

CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)
por: Eaton, S. L., et al.
Publicado: (2019)

Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis
por: Geraets, Ryan D., et al.
Publicado: (2016)

Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD
por: van der Zee, Julie, et al.
Publicado: (2016)

Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights
por: Ostergaard, John R
Publicado: (2016)

Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease
Publicado: (2019)

Neuronal ceroid lipofuscinosis type 2: an Australian case series
por: Johnson, Alexandra M, et al.
Publicado: (2020)

Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview
por: Simonati, Alessandro, et al.
Publicado: (2022)

Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers
por: Kozina, Anastasiya A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j3590t3p0nmflc3ukjhhka3po6